The Company

An introduction

Oxtex, incorporated in May 2011, is a medical device company which has developed a novel autonomous controlled tissue expander for the use in reconstructive surgery based on technology developed originally at Oxford University. 

Oxtex has secured its IP through several international patents to protect the know-how and design of its products. Through collaboration and support of internationally renowned veterinary specialists the company has successfully produced and internationally commercialised its veterinary product, Expaniderm.

The Oxtex technology has been recognised by the business community; the company received the OBN awards for Best Emerging MedTech in late 2011 and best New Medical Product in 2012, the UK Enterprise Awards for Innovation in Tissue Expansion Solutions in 2018, and won the WOBA Owen Mumford Innovation Award 2019.

The Company has a very experienced Board of Directors and is further supported by a Scientific Advisory Board of internationally recognised academics and clinicians.


Tissue expansion is commonly used in human reconstructive surgery to grow extra skin through controlled mechanical overstretch.

Read more


Expaniderm is the first in a new class of implantable soft tissue expanders, offering control, reliability and convenience.

Read more